PDLIM2 and cancer: Mechanistically, the main function of PDLIM2 in cancer is to promote ubiquitination and proteasomal degradation of nuclear activated nuclear factor-κB RelA and STAT3 to increase the expression of genes involved in antigen presentation and T-cell activation, which leads to inhibition of malignant tumors12,13.